Williams-Sonoma Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Williams-Sonoma Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Williams-Sonoma, Inc. (NYSE:WSM) is set to release earnings results for its first quarter, before the opening bell on May 22.
威廉姆斯-索诺玛公司（纽约证券交易所代码：WSM）将在5月22日开盘前公布其第一季度财报。
Analysts expect the San Francisco, California-based company to report quarterly earnings at $2.68 per share, up from $2.64 per share in the year-ago period. Williams-Sonoma is projected to report quarterly revenue of $1.65 billion, according to data from Benzinga Pro.
分析师预计，这家总部位于加利福尼亚州旧金山的公司将公布的季度收益为每股2.68美元，高于去年同期的每股2.64美元。根据Benzinga Pro的数据，威廉姆斯-索诺玛预计将公布16.5亿美元的季度收入。
On March 13, Williams-Sonoma posted better-than-expected earnings for its fourth quarter. The company announced a new $1 billion stock repurchase authorization and increased its quarterly dividend.
3月13日，威廉姆斯-索诺玛公布的第四季度收益好于预期。该公司宣布了新的10亿美元股票回购授权，并增加了季度股息。
Williams-Sonoma shares fell 0.7% to close at $314.38 on Tuesday.
周二，威廉姆斯-索诺玛股价下跌0.7％，收于314.38美元。
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Benzinga的读者可以在分析师股票评级页面上访问最新的分析师评级。读者可以按股票行情、公司名称、分析公司、评级变化或其他变量进行排序。
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
让我们来看看Benzinga最准确的分析师在最近一段时间对该公司的评级。
- Wedbush analyst Seth Basham maintained an Outperform rating and raised the price target from $330 to $350 on May 17. This analyst has an accuracy rate of 72%.
- Evercore ISI Group analyst Oliver Wintermantel maintained an In-Line rating and increased the price target from $310 to $315 on May 14. This analyst has an accuracy rate of 73%.
- JP Morgan analyst Christopher Horvers upgraded the stock from Underweight to Neutral and boosted the price target from $245 to $275 on May 3. This analyst has an accuracy rate of 72%.
- Telsey Advisory Group analyst Joseph Feldman maintained an Outperform rating and boosted the price target from $320 to $340 on March 25. This analyst has an accuracy rate of 73%.
- Barclays analyst Adrienne Yih maintained an Underweight rating and raised the price target from $146 to $232 on March 15. This analyst has an accuracy rate of 69%.
- Wedbush分析师塞思·巴沙姆维持跑赢大盘的评级，并于5月17日将目标股价从330美元上调至350美元。这位分析师的准确率为72％。
- Evercore ISI集团分析师奥利弗·温特曼特尔维持在线评级，并于5月14日将目标股价从310美元上调至315美元。这位分析师的准确率为73％。
- 摩根大通分析师克里斯托弗·霍弗斯于5月3日将该股从减持上调至中性，并将目标股价从245美元上调至275美元。这位分析师的准确率为72％。
- 泰尔西咨询集团分析师约瑟夫·费尔德曼维持跑赢大盘的评级，并于3月25日将目标股价从320美元上调至340美元。这位分析师的准确率为73％。
- 巴克莱分析师叶艾德丽安维持减持评级，并于3月15日将目标股价从146美元上调至232美元。该分析师的准确率为69％。
Read This Next: Jim Cramer Calls This Healthcare Stock A 'Worthy Spec,' Recommends Avoiding Canada Goose
接下来阅读这篇文章：吉姆·克莱默称这只医疗保健股为 “值得关注的规格”，建议避开 Canada Goose
译文内容由第三方软件翻译。